Aktiia received FDA clearance in July for the first cuffless blood pressure monitor authorized to be sold over the counter.

The minimally invasive system uses radiofrequency energy to target nerve tissue causing facial pain.

The startup intends to make a small patch pump with a closed-loop algorithm for nighttime glucose control.

O’Hara joins CMR’s executive team as commercial president and general manager for the U.S., following the FDA’s authorization ...

CEO Geoff Martha told investors that the initiatives were done in partnership with the activist investor firm Elliott ...

The FDA said the request to quarantine the devices followed reports of the products “resisting shape retention when being ...

July and August have brought a steady beat of private financings for young medtech companies, with several deals supporting ...

The investment includes increasing manufacturing and research and development capabilities at its Reedsville, Pennsylvania, ...

The president indicated that duties on chips would be “approximately 100%” earlier this month.

The fresh funding will support pivotal trials in progress and commercialization preparations at the two heart-focused ...

Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.

The records system is available for U.S. ambulatory providers, pending regulatory approval. Oracle plans to launch in the ...